Literature DB >> 2403474

Human immunodeficiency virus (HIV) infection and the kidney.

R J Glassock1, A H Cohen, G Danovitch, K P Parsa.   

Abstract

Since the first report on the acquired immunodeficiency syndrome (AIDS) in 1981, organ involvement of AIDS has increased. We discuss the effect of human immunodeficiency virus (HIV) infection, the causative agent of AIDS, on the field of nephrology. Hyponatremia, the commonest fluid and electrolyte abnormality, is caused by various pathophysiologic mechanisms, including adrenal insufficiency. The renal parenchymal complications are diverse, but a new entity, HIV-associated nephropathy, is becoming recognized because of its characteristic clinical and pathologic features, including the fact that it causes irreversible renal failure. HIV infection in patients with end-stage renal failure, both before and after initiation of maintenance dialysis, is a significant problem. The present methods of preventing spread of virus in dialysis units seem successful. Few patients who are infected with HIV or who have AIDS have had renal transplantation, although unsuspected viral infection of cadaveric organs remains a concern.

Entities:  

Mesh:

Year:  1990        PMID: 2403474     DOI: 10.7326/0003-4819-112-1-35

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  24 in total

1.  Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis.

Authors:  D M Grasela; R R Stoltz; M Barry; M Bone; B Mangold; P O'Grady; R Raymond; S J Haworth
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.

Authors:  A Karpas; M Lowdell; S K Jacobson; F Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

3.  [Reversible space-occupying lesions of the kidney in HIV infection].

Authors:  J R Bogner; W G Zoller; M Middeke
Journal:  Klin Wochenschr       Date:  1990-10-17

4.  Safe Treatment of Seizures in the Setting of HIV/AIDS.

Authors:  Omar Siddiqi; Gretchen L Birbeck
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

Review 5.  Hypertension in the HIV-infected patient.

Authors:  S Aoun; E Ramos
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

6.  Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.

Authors:  A E Heald; P H Hsyu; G J Yuen; P Robinson; P Mydlow; J A Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

7.  End-stage renal disease in patients infected with human immunodeficiency virus: a retrospective review of 38 cases.

Authors:  O O Obayomi; M G Dillard; A O Hosten; I A Cruz
Journal:  J Natl Med Assoc       Date:  1995-10       Impact factor: 1.798

8.  Pelvocalyceal thickening in HIV-associated nephropathy.

Authors:  R H Wachsberg; A T Obolevich; N Lasker
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

9.  Myeloma-like cast nephropathy caused by human recombinant soluble CD4 (sCD4) in monkeys.

Authors:  P J Bugelski; H A Solleveld; K L Fong; A M Klinkner; T K Hart; D G Morgan
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

10.  Electrolyte disorders and renal dysfunction in acquired immunodeficiency syndrome patients.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1991-10       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.